Digital tracking pill gets FDA approval U.S. regulators approved the first medicine with an embedded sensor to help keep track of whether patients with mental illness are adhering to their prescriptions. The decision marks a milestone in the convergence of technology and health care that also raises privacy concerns. The so-called digital pill is a version of Otsuka Pharmaceutical Co.'s Abilify, which treats depression, bipolar disorder and schizophrenia.Read more on NewsOK.com